226 related articles for article (PubMed ID: 16980582)
21. Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors.
Petit AM; Rak J; Hung MC; Rockwell P; Goldstein N; Fendly B; Kerbel RS
Am J Pathol; 1997 Dec; 151(6):1523-30. PubMed ID: 9403702
[TBL] [Abstract][Full Text] [Related]
22. Differential vascular and transcriptional responses to anti-vascular endothelial growth factor antibody in orthotopic human pancreatic cancer xenografts.
Bockhorn M; Tsuzuki Y; Xu L; Frilling A; Broelsch CE; Fukumura D
Clin Cancer Res; 2003 Sep; 9(11):4221-6. PubMed ID: 14519649
[TBL] [Abstract][Full Text] [Related]
23. Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster.
Dews M; Homayouni A; Yu D; Murphy D; Sevignani C; Wentzel E; Furth EE; Lee WM; Enders GH; Mendell JT; Thomas-Tikhonenko A
Nat Genet; 2006 Sep; 38(9):1060-5. PubMed ID: 16878133
[TBL] [Abstract][Full Text] [Related]
24. TNFR1 signaling and IFN-gamma signaling determine whether T cells induce tumor dormancy or promote multistage carcinogenesis.
Müller-Hermelink N; Braumüller H; Pichler B; Wieder T; Mailhammer R; Schaak K; Ghoreschi K; Yazdi A; Haubner R; Sander CA; Mocikat R; Schwaiger M; Förster I; Huss R; Weber WA; Kneilling M; Röcken M
Cancer Cell; 2008 Jun; 13(6):507-18. PubMed ID: 18538734
[TBL] [Abstract][Full Text] [Related]
25. Emodin inhibits vascular endothelial growth factor-A-induced angiogenesis by blocking receptor-2 (KDR/Flk-1) phosphorylation.
Kwak HJ; Park MJ; Park CM; Moon SI; Yoo DH; Lee HC; Lee SH; Kim MS; Lee HW; Shin WS; Park IC; Rhee CH; Hong SI
Int J Cancer; 2006 Jun; 118(11):2711-20. PubMed ID: 16388516
[TBL] [Abstract][Full Text] [Related]
26. Up-Regulation of Bcl-2 in microvascular endothelial cells enhances intratumoral angiogenesis and accelerates tumor growth.
Nör JE; Christensen J; Liu J; Peters M; Mooney DJ; Strieter RM; Polverini PJ
Cancer Res; 2001 Mar; 61(5):2183-8. PubMed ID: 11280784
[TBL] [Abstract][Full Text] [Related]
27. Increased invasiveness of MMP-9-deficient tumors in two mouse models of neuroendocrine tumorigenesis.
Shchors K; Nozawa H; Xu J; Rostker F; Swigart-Brown L; Evan G; Hanahan D
Oncogene; 2013 Jan; 32(4):502-13. PubMed ID: 22391572
[TBL] [Abstract][Full Text] [Related]
28. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis.
Bergers G; Brekken R; McMahon G; Vu TH; Itoh T; Tamaki K; Tanzawa K; Thorpe P; Itohara S; Werb Z; Hanahan D
Nat Cell Biol; 2000 Oct; 2(10):737-44. PubMed ID: 11025665
[TBL] [Abstract][Full Text] [Related]
29. c-Myc enhances colon cancer cell-mediated angiogenesis through the regulation of HIF-1α.
Chen C; Cai S; Wang G; Cao X; Yang X; Luo X; Feng Y; Hu J
Biochem Biophys Res Commun; 2013 Jan; 430(2):505-11. PubMed ID: 23237807
[TBL] [Abstract][Full Text] [Related]
30. Lentivirus-mediated shRNA interference targeting vascular endothelial growth factor inhibits angiogenesis and progression of human pancreatic carcinoma.
Zhao X; Zhu DM; Gan WJ; Li Z; Zhang JL; Zhao H; Zhou J; Li DC
Oncol Rep; 2013 Mar; 29(3):1019-26. PubMed ID: 23254994
[TBL] [Abstract][Full Text] [Related]
31. BCL-x(L) and BCL2 delay Myc-induced cell cycle entry through elevation of p27 and inhibition of G1 cyclin-dependent kinases.
Greider C; Chattopadhyay A; Parkhurst C; Yang E
Oncogene; 2002 Nov; 21(51):7765-75. PubMed ID: 12420213
[TBL] [Abstract][Full Text] [Related]
32. Modulation of c-Myc activity and apoptosis in vivo.
Alarcon RM; Rupnow BA; Graeber TG; Knox SJ; Giaccia AJ
Cancer Res; 1996 Oct; 56(19):4315-9. PubMed ID: 8813114
[TBL] [Abstract][Full Text] [Related]
33. The role of macrophage-derived IL-1 in induction and maintenance of angiogenesis.
Carmi Y; Voronov E; Dotan S; Lahat N; Rahat MA; Fogel M; Huszar M; White MR; Dinarello CA; Apte RN
J Immunol; 2009 Oct; 183(7):4705-14. PubMed ID: 19752225
[TBL] [Abstract][Full Text] [Related]
34. Acinar-to-ductal metaplasia accompanies c-myc-induced exocrine pancreatic cancer progression in transgenic rodents.
Grippo PJ; Sandgren EP
Int J Cancer; 2012 Sep; 131(5):1243-8. PubMed ID: 22024988
[TBL] [Abstract][Full Text] [Related]
35. Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors.
Casanovas O; Hicklin DJ; Bergers G; Hanahan D
Cancer Cell; 2005 Oct; 8(4):299-309. PubMed ID: 16226705
[TBL] [Abstract][Full Text] [Related]
36. Mechanism for IL-1 beta-mediated neovascularization unmasked by IL-1 beta knock-out mice.
Amano K; Okigaki M; Adachi Y; Fujiyama S; Mori Y; Kosaki A; Iwasaka T; Matsubara H
J Mol Cell Cardiol; 2004 Apr; 36(4):469-80. PubMed ID: 15081307
[TBL] [Abstract][Full Text] [Related]
37. Tumor growth suppression in pancreatic cancer by a putative metastasis suppressor gene Cap43/NDRG1/Drg-1 through modulation of angiogenesis.
Maruyama Y; Ono M; Kawahara A; Yokoyama T; Basaki Y; Kage M; Aoyagi S; Kinoshita H; Kuwano M
Cancer Res; 2006 Jun; 66(12):6233-42. PubMed ID: 16778198
[TBL] [Abstract][Full Text] [Related]
38. Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis.
Nozawa H; Chiu C; Hanahan D
Proc Natl Acad Sci U S A; 2006 Aug; 103(33):12493-8. PubMed ID: 16891410
[TBL] [Abstract][Full Text] [Related]
39. Angiopoietin-1 and -2 exert antagonistic functions in tumor angiogenesis, yet both induce lymphangiogenesis.
Fagiani E; Lorentz P; Kopfstein L; Christofori G
Cancer Res; 2011 Sep; 71(17):5717-27. PubMed ID: 21778249
[TBL] [Abstract][Full Text] [Related]
40. The RNA methyltransferase Misu (NSun2) mediates Myc-induced proliferation and is upregulated in tumors.
Frye M; Watt FM
Curr Biol; 2006 May; 16(10):971-81. PubMed ID: 16713953
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
